About MedKairos
MedKairos is a company based in Ann Arbor (United States) founded in 2017 by Michael Moore. MedKairos has raised $365 thousand across 1 funding round. MedKairos operates in a competitive market with competitors including Atrys, EDP Biotech Corporation, C the Signs, inveox and Nanovery, among others.
- Headquarter Ann Arbor, United States
- Founders Michael Moore
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$365 K (USD)
in 1 rounds
-
Latest Funding Round
$365 K (USD), Seed
Aug 13, 2018
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of MedKairos
MedKairos has successfully raised a total of $365K through 1 strategic funding round. The most recent funding activity was a Seed round of $365 thousand completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by MedKairos
Investment portfolio details for MedKairos
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MedKairos
Detailed financials for MedKairos
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medkairos Comparisons
Peer comparison for MedKairos
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MedKairos
MedKairos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Atrys, EDP Biotech Corporation, C the Signs, inveox and Nanovery, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic and therapeutic services catering to cancer
|
|
| Locked | Locked | Locked |
Offers online purchase of diagnostic test kits and lab appointment scheduling services.
|
|
| Locked | Locked | Locked |
Platform offering cancer prediction system for early cancer detection
|
|
| Locked | Locked | Locked |
Automated solutions for biopsy sample preparation in laboratories are provided.
|
|
| Locked | Locked | Locked |
Nanobots are developed for cancer diagnosis through bloodstream administration.
|
|
| Locked | Locked | Locked |
Digital pathology solutions for cancer diagnostics are developed by Inspirata.
|
Detailed competitors of MedKairos
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medkairos
Complete news archive for MedKairos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MedKairos
MedKairos was founded in 2017 and raised its 1st funding round 1 year after it was founded.
MedKairos is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Michael Moore is the current CEO of MedKairos. They have also founded this company.
MedKairos is a funded company, having raised a total of $365K across 1 funding round to date.
MedKairos was founded in 2017 in Ann Arbor, United States, within the medical technology sector. A device known as the Bioptic system is developed, integrating machine learning and microfluidics to automate the cancer biopsy process. Accuracy of sample collection is improved, and clinical decision-making is supported through these technologies. Operations focus on enhancing diagnostic precision for oncology applications.
MedKairos's top competitors include Atrys, inveox and C the Signs.